Diaprost Licenses its novel Theranostic Antibody, hu5A10, to Radiopharm Theranostics for Development in the Treatment and Diagnosis of Prostate Cancer. ...Middle East

News by : (PR Newswire) -

Read More Details
Finally We wish PressBee provided you with enough information of ( Diaprost Licenses its novel Theranostic Antibody, hu5A10, to Radiopharm Theranostics for Development in the Treatment and Diagnosis of Prostate Cancer. )

Also on site :

Most Viewed News
جديد الاخبار